Aim: The ability of nicotine to modify withdrawal symptoms in rats chronically treated with alcohol, with respect to locomotor activity and ethanol or nicotine preference, has been evaluated in these studies.
Methods And Results: Preliminary studies showed that locomotor activity increased 8-9 h after withdrawal from chronic nicotine intoxication, which was dose specific; it occurred in rats administered 0.15 mg/kg or 0.6 mg/kg but not the 0.3 mg/kg nicotine dose. Administration of nicotine, either acutely (0.3 mg/kg) during ethanol withdrawal, or chronically (0.15, 0.3 or 0.6 mg/kg) during the chronic alcohol treatment procedure, diminished locomotor activity, which increases significantly, approximately 6-7 h after withdrawal, in rats chronically treated with alcohol. Rats which were chronically treated with alcohol alone or in combination with nicotine, 0.3 mg/kg, showed an increase in ethanol intake when the free choice was performed between ethanol 10% and tap water; on the contrary, when the free choice was performed between ethanol 10% versus nicotine, 0.3 mg/kg, results showed a decrease in ethanol preference and a concomitant increase in nicotine preference.
Conclusion: These studies clearly identified the modulatory effects of nicotine, at specific doses, on both motility and preference in rat chronically co-administered nicotine and ethanol.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/alcalc/agm023 | DOI Listing |
Sci Rep
January 2025
Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory of Coal Environmental Pathogenicity and Prevention (Ministry of Education, China, Shanxi Medical University, No. 56, Xinjian South Road, Yingze District, Taiyuan City, 030000, Shanxi Province, China.
There are many similarities between early embryonic development and tumorigenesis. The occurrence of neural tube defects (NTDs) and glioblastoma (GBM) are both related to the abnormal development of neuroectodermal cells. To obtain genes related to both NTDs and GBM, as well as small molecule drugs with potential clinical application value.
View Article and Find Full Text PDFExp Neurol
January 2025
Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China; The Marine Biomedical Research Institute of Guangdong, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524000, China. Electronic address:
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model remains the most extensively utilized animal model for Parkinson's disease (PD). Treatment regimens are classified into three categories: acute, subacute, and chronic. Among these, the MPTP with probenecid (MPTP/p)-induced chronic mouse model is favored for its capacity to sustain long-term striatal dopamine depletion, though the resultant behavioral, biochemical, and molecular alterations require further validation.
View Article and Find Full Text PDFExp Neurol
January 2025
Thomas Jefferson University, Thomas Jefferson University, Department of Physical Medicine and Rehabilitation, Philadelphia, PA, USA.
Pre-clinical research is intended to inform clinical research, however, communication between these researchers is lacking. A better understanding of what can be learned from animal and human models and what cannot, is essential. This includes a better understanding of where underlying constructs in outcome measures in rodents and humans align and where they diverge to improve dialogue between human and animal researchers.
View Article and Find Full Text PDFGait Posture
January 2025
Department of Mechanical Engineering, University of Washington, Seattle, WA, USA; Center for Research and Education on Accessible Technology and Experiences, University of Washington, Seattle, WA, USA. Electronic address:
Background: Children with cerebral palsy (CP) have an injury to the central nervous system around the time of birth that affects the development of the brain and spinal cord. This injury leads to changes in gait neuromechanics, including muscle activity and joint kinematics. Transcutaneous spinal cord stimulation (tSCS) is a novel neuromodulation technique that may improve movement and coordination in children with CP when paired with targeted physical therapy.
View Article and Find Full Text PDFJ Biomech
January 2025
Department of Kinesiology, University of Massachusetts Amherst, Amherst, MA, United States; School of Kinesiology, University of Michigan, Ann Arbor, MI, United States.
Humans typically choose to walk at a self-selected stride frequency that minimizes their metabolic cost. However, when environmental constraints are present (e.g.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!